Document is current
Any future updates will be listed below
-
Authors
Lapevandani, Mahsa Mohammadi
Khodadadi, Sanaz
Naghitehrani, Khadije Haji
Ayoubi, Saeideh
Eskandarieh, Sharareh
Sahraian, Mohammad Ali
-
Funding
Funding for this research was provided by:
Tehran University of Medical Sciences and Health Services (1403-2-101-73381)
- License Information
-
More Information
Article History
Received: 6 April 2025
Accepted: 24 December 2025
First Online: 30 January 2026
Declarations
:
: The study protocol was approved by the ethics committee of the Tehran University of Medical Sciences by the code IR.TUMS.NI.REC.1403.030.The current study adhered to the Declaration of Helsinki.The study was conducted using data obtained from the national multiple sclerosis registry system. Written informed consent to participate and for the use of clinical data for research purposes was obtained from all participants at the time of enrollment in the registry.
: Not applicable.
: Conflict of Interest: M.A.S: I have received educational, research grants, lecture honorarium, travel supports to attend scientific meetings from Biogen-Idec, Merck-Serono, Cinnagen, Zistdaru, Zahravi and Genzyme. Others: none.
